BioCentury
ARTICLE | Company News

Genentech, Houston Biotechnology deal

October 3, 1994 7:00 AM UTC

The two companies mutually agreed to end a collaboration under which GNE (South San Francisco) was testing HBI's lung-derived neurotrophic factor (LDNF) for non-ophthalmic indications. HBI told BioCentury that GNE encountered difficulties with the purification process. ...